Publisher
Akshantala Enterprises Private Limited
Reference18 articles.
1. 1. Wallidius G, Jungner Apo lipoprotein B and Apo lipoprotein A: Risk indicators of coronary heart disease and targets for lipid modifying therapy, Jntern Mod 2004: 255: 188: 205.
2. 2. Huges Lo, Raval U, Rafteny EB. First myocardial infarction in Asian and white men. BMJ 1989, 298, 1345-1350.
3. 3. Lawn RM, Lipoprotein (a) in heart disease. Sci Am 1992, 266, 54-60.
4. 4. Berglund L. Diet and drug therapy for lipoprotein (a) curr opin lipidol 1995; 6: 48-56.
5. 5. Garcia -Dia2 JD, Gasper Blazquez MJ. Effect of LP (a) as a risk factor of coronary artery disease in adults aged less than 65 years in function of gender difference. Rev. clin Esp 2003; 203: 125-132.